- ►angrylapdog.com J Weissberg-Benchell, J Antisdel-Lomaglio, R … - Diabetes Care, 2003 - care.diabetesjournals.org.p.angrylapdog.com RESEARCH DESIGN AND METHODS—Studies were identified and data regarding study
design, year of publication, sample size, patient's age, diabetes duration, and
duration of CSII therapy were collected. Means and SDs for glycohemoglobin, ... Cited by 295 - Related articles - BL Direct - All 14 versions
- ►juanncorpas.edu.co [PDF] DE DeWitt, IB Hirsch - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Newer insulin ... Cited by 273 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org LP Plotnick, LM Clark, FL Brancati, T Erlinger - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—There was a small but significant decrease in HbA 1c at 3–6 months
after pump start (7.7 vs. 7.5%; P = 0.03). HbA 1c levels then gradually
increased and remained elevated after 1 year of follow-up; however, this ... Cited by 146 - Related articles - BL Direct - All 10 versions
- ►diabetesjournals.org [PDF] R Retnakaran, B Zinman - Diabetes Care, 2005 - Am Diabetes Assoc Cardiac ventricles release B-type na- triuretic peptide (BNP) in response to
volume expansion and pressure overload; therefore, BNP concentration may be used
as a biochemical marker of cardiac failure (1). BNP levels are high in ... Cited by 95 - Related articles - BL Direct - All 8 versions
WH Herman, LL Ilag, SL Johnson, CL Martin, J … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Forty-eight CSII subjects (91%) and 50 MDI subjects (93%) completed
the study. Mean A1C fell by 1.7 ± 1.0% in the CSII group to 6.6% and by 1.6 ±
1.2% in the MDI group to 6.4%. The difference in A1C between treatment ... Cited by 85 - Related articles - BL Direct - All 5 versions
JH DeVries, FJ Snoek, PJ Kostense, N … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—As the drop-out rate after crossover was high (17 of 79 patients
[22%]), we analyzed the trial as a parallel clinical trial, using data of the
first half of the crossover phase only. At 16 weeks, mean HbA 1c was 0.84% ... Cited by 77 - Related articles - BL Direct - All 6 versions
JL Colquitt, C Green, MK Sidhu, D Hartwell, …, 2004 - nice.org.uk Page 1. Clinical and cost-effectiveness of CSII for diabetes - CONFIDENTAL
CLINICAL AND COST EFFECTIVENESS OF CONTINUOUS SUBCUTANEOUS ... Cited by 60 - Related articles - View as HTML - All 10 versions
- ►diabetesjournals.org IB Hirsch, BW Bode, S Garg, WS Lane, A … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Mean serum fructosamine levels were significantly lower after CSII
therapy than after MDI therapy (343 ± 47 vs. 355 ± 50 μmol/l, respectively; P
= 0.0001). Continuous glucose monitoring profiles over a 24-h time period ... Cited by 45 - Related articles - All 7 versions
SK Garg, AJ Walker, HK Hoff, AO D'Souza, PA … - Diabetes Technology & Therapeutics, 2004 - liebertonline.com This study compared external insulin pump treatment using insulin lispro or
insulin aspart with multiple daily injections (MDI; four or more injections per
day) using insulin glargine and insulin lispro or insulin aspart. An ... Cited by 33 - Related articles - BL Direct - All 3 versions
